Background Plasma fibrinogen may be involved in several stages of cancer progression.
Clinical studies have demonstrated that pretreatment plasma fibrinogen is associated with …

Coagulation is a highly conserved process occurring after an injury to a blood vessel and
resulting in hemostasis. In the thrombus microenvironment, finely orchestrated events …

Background Gene set analysis (GSA) is a widely used strategy for gene expression data
analysis based on pathway knowledge. GSA focuses on sets of related genes and has …

Background Systemic activation of hemostasis is frequently observed in cancer patients,
even in the absence of thrombosis. Moreover, this activation has been implicated in tumor …

Objective Although the significance of increased plasma D-dimer levels in activating
coagulation and fibrinolysis has been reported, it is still controversial whether it can be used …

Abstract Background/Aims: Elevated pretreatment plasma D-dimer level has been reported
as an unfavorable prognostic indicator in several malignancies. The aim of this meta …

Activation of coagulation and fibrinolysis is frequently encountered among cancer patients.
Such tumors are supposed to be associated with higher risk of invasion, metastases and …

Venous thromboembolism (VTE) is a common complication of malignancies and
epidemiological studies suggest that lung cancer belonged to the group of malignancies …

Objective The study aimed to evaluate the prognostic value of pretreatment plasma
dimerized plasmin fragment D (D-dimer), fibrinogen, and platelet levels in epithelial ovarian …

Malignant disease is characterized by a hemostatic imbalance, usually shifted towards a
procoagulant direction, and a high incidence of thrombotic complications. The mechanisms …